  0 Table of Contents |
  1 Home |
 2 Artifacts Summary |
 2.1 admission-source-code |
| 2.2 adverse-event-severity |
| 2.3 AIR diseases covered code |
| 2.4 AIR route of administration |
| 2.5 AIR status reason code |
| 2.6 alias-type-code |
| 2.7 allergy-intolerance-category |
| 2.8 allergy-intolerance-type |
| 2.9 allergyintolerance-clinical |
| 2.10 anzsco |
| 2.11 ATC value set |
| 2.12 Body Site - IPS |
| 2.13 Building type code |
| 2.14 canshare-moh-refcrit-colonoscopy-2w |
| 2.15 clinical-code-type-code |
| 2.16 Common UCUM units |
| 2.17 condition-ver-status |
| 2.18 Condition/Diagnosis Severity |
| 2.19 contact-point-purpose-code |
| 2.20 Currency |
| 2.21 Current Smoking Status - IPS |
| 2.22 CVDRA Angina |
| 2.23 CVDRA Coronary Artery Bypass Grafting |
| 2.24 CVDRA Diabetes |
| 2.25 CVDRA Family History Of Premature Ischaemic CVD |
| 2.26 CVDRA Heart failure |
| 2.27 CVDRA Hypercholesterolaemia |
| 2.28 CVDRA Ischaemic Stroke |
| 2.29 CVDRA Percutaneous Coronary Intervention |
| 2.30 CVDRA Peripheral Vascular Disease |
| 2.31 CVDRA Renal Failure |
| 2.32 CVDRA Smoking Status |
| 2.33 CVDRA Transient Ischaemic Attack (TIA) |
| 2.34 Death date Information Source |
| 2.35 dhb-code |
| 2.36 DocumentMode |
| 2.37 domicile-code |
| 2.38 Dwelling type |
| 2.39 ethnic-group-level-4-code |
| 2.40 Health NZ language Value Set |
| 2.41 Health service type refset vs |
| 2.42 hpi-practitioner-role-status-reason-code |
| 2.43 ISO 639 2 and 3 language codes |
| 2.44 iso3166-1-2 |
| 2.45 iwi-code |
| 2.46 Medications - SNOMED CT (IPS) |
| 2.47 Medicine Active Substances - IPS |
| 2.48 NZ AJCC (8th edition) breast clinical N category |
| 2.49 NZ AJCC (8th edition) breast clinical stage group |
| 2.50 NZ AJCC (8th edition) breast clinical T category |
| 2.51 NZ AJCC (8th edition) breast pathological N category |
| 2.52 NZ AJCC (8th edition) breast pathological T category |
| 2.53 NZ AJCC (8th edition) edition residual tumour category |
| 2.54 NZ AJCC (8th edition) female genital cervix uteri clinical M category |
| 2.55 NZ AJCC (8th edition) female genital cervix uteri pathological T category |
| 2.56 NZ AJCC (8th edition) female genital cervix uteri stage group |
| 2.57 NZ AJCC (8th edition) female genital clinical N category |
| 2.58 NZ AJCC (8th edition) female genital clinical T category |
| 2.59 NZ AJCC (8th edition) female genital corpus uteri adenosarcoma clinical T category |
| 2.60 NZ AJCC (8th edition) female genital corpus uteri adenosarcoma pathological T category |
| 2.61 NZ AJCC (8th edition) female genital corpus uteri carcinoma and carcinosarcoma clinical T category |
| 2.62 NZ AJCC (8th edition) female genital corpus uteri carcinoma and carcinosarcoma stage group |
| 2.63 NZ AJCC (8th edition) female genital corpus uteri clinical N category |
| 2.64 NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical N category |
| 2.65 NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical T category |
| 2.66 NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma pathological T category |
| 2.67 NZ AJCC (8th edition) female genital corpus uteri pathological N category |
| 2.68 NZ AJCC (8th edition) female genital corpus uteri pathological T category |
| 2.69 NZ AJCC (8th edition) female genital corpus uteri stage group |
| 2.70 NZ AJCC (8th edition) female genital gestational trophoblastic disease pathological M category |
| 2.71 NZ AJCC (8th edition) female genital gestational trophoblastic disease stage group |
| 2.72 NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma clinical M category |
| 2.73 NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma clinical T category |
| 2.74 NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma pathological M category |
| 2.75 NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma pathological N category |
| 2.76 NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma stage group |
| 2.77 NZ AJCC (8th edition) female genital pathological M category |
| 2.78 NZ AJCC (8th edition) female genital pathological T category |
| 2.79 NZ AJCC (8th edition) female genital stage group |
| 2.80 NZ AJCC (8th edition) female genital vagina pathological M category |
| 2.81 NZ AJCC (8th edition) female genital vagina pathological T category |
| 2.82 NZ AJCC (8th edition) female genital vagina stage group |
| 2.83 NZ AJCC (8th edition) female genital vulva clinical M category |
| 2.84 NZ AJCC (8th edition) female genital vulva clinical N category |
| 2.85 NZ AJCC (8th edition) female genital vulva pathological M category |
| 2.86 NZ AJCC (8th edition) female genital vulva pathological N category |
| 2.87 NZ AJCC (8th edition) female genital vulva pathological T category |
| 2.88 NZ AJCC (8th edition) female genital vulva stage group |
| 2.89 NZ AJCC (8th edition) gastrointestinal clinical stage group |
| 2.90 NZ AJCC (8th edition) gastrointestinal colon and rectum clinical N category |
| 2.91 NZ AJCC (8th edition) gastrointestinal colon and rectum clinical T category |
| 2.92 NZ AJCC (8th edition) gastrointestinal colon and rectum pathological M category |
| 2.93 NZ AJCC (8th edition) gastrointestinal colon and rectum pathological N category |
| 2.94 NZ AJCC (8th edition) gastrointestinal colon and rectum pathological T category |
| 2.95 NZ AJCC (8th edition) gastrointestinal colon and rectum stage group |
| 2.96 NZ AJCC (8th edition) gastrointestinal pathological N category |
| 2.97 NZ AJCC (8th edition) gastrointestinal pathological post therapy (neoadjuvant) stage group |
| 2.98 NZ AJCC (8th edition) gastrointestinal pathological stage group |
| 2.99 NZ AJCC (8th edition) gastrointestinal pathological T category |
| 2.100 NZ AJCC (8th edition) gastrointestinal stromal tumour clinical N category |
| 2.101 NZ AJCC (8th edition) gastrointestinal stromal tumour clinical T category |
| 2.102 NZ AJCC (8th edition) gastrointestinal stromal tumour pathological M category |
| 2.103 NZ AJCC (8th edition) gastrointestinal stromal tumour pathological N category |
| 2.104 NZ AJCC (8th edition) gastrointestinal stromal tumour pathological T category |
| 2.105 NZ AJCC (8th edition) haematology clinical M category |
| 2.106 NZ AJCC (8th edition) haematology clinical N category |
| 2.107 NZ AJCC (8th edition) haematology clinical T category |
| 2.108 NZ AJCC (8th edition) haematology cutaneous B cell or T cell non mycosis fungoides and non sezary syndrome lymphoma pathological M category |
| 2.109 NZ AJCC (8th edition) haematology Hodgkin or non Hodgkin lymphoma stage group |
| 2.110 NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical M category |
| 2.111 NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical N category |
| 2.112 NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical T category |
| 2.113 NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological M category |
| 2.114 NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological N category |
| 2.115 NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological T category |
| 2.116 NZ AJCC (8th edition) haematology pathological N category |
| 2.117 NZ AJCC (8th edition) haematology pediatric Hodgkin lymphoma stage group |
| 2.118 NZ AJCC (8th edition) haematology plasma cell myeloma stage group |
| 2.119 NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical M category |
| 2.120 NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical T category |
| 2.121 NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma pathological T category |
| 2.122 NZ AJCC (8th edition) haematology stage group |
| 2.123 NZ AJCC (8th edition) neuroendocrine gastrointestinal clinical N category |
| 2.124 NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum clinical M category |
| 2.125 NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum clinical N category |
| 2.126 NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum pathological M category |
| 2.127 NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum pathological T category |
| 2.128 NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological M category |
| 2.129 NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological N category |
| 2.130 NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological T category |
| 2.131 NZ AJCC (8th edition) neuroendocrine gastrointestinal stage group |
| 2.132 NZ AJCC (8th edition) thoracic clinical M category |
| 2.133 NZ AJCC (8th edition) thoracic lung clinical T category |
| 2.134 NZ AJCC (8th edition) thoracic lung pathological N category |
| 2.135 NZ AJCC (8th edition) thoracic lung pathological T category |
| 2.136 NZ AJCC (8th edition) thoracic lung stage group |
| 2.137 NZ AJCC (8th edition) thoracic malignant pleural mesothelioma clinical N category |
| 2.138 NZ AJCC (8th edition) thoracic malignant pleural mesothelioma clinical T category |
| 2.139 NZ AJCC (8th edition) thoracic malignant pleural mesothelioma pathological M category |
| 2.140 NZ AJCC (8th edition) thoracic malignant pleural mesothelioma stage group |
| 2.141 NZ AJCC (8th edition) thoracic pathological N category |
| 2.142 NZ AJCC (8th edition) thoracic pathological T category |
| 2.143 NZ AJCC (8th edition) thoracic thymus clinical M category |
| 2.144 NZ AJCC (8th edition) thoracic thymus clinical N category |
| 2.145 NZ AJCC (8th edition) thoracic thymus pathological M category |
| 2.146 NZ AJCC (8th edition) thoracic thymus stage group |
| 2.147 NZ AJCC (9th edition) female genital cervix uteri clinical M category |
| 2.148 NZ AJCC (9th edition) female genital cervix uteri clinical N category |
| 2.149 NZ AJCC (9th edition) female genital cervix uteri clinical T category |
| 2.150 NZ AJCC (9th edition) female genital cervix uteri pathological T category |
| 2.151 NZ AJCC (9th edition) female genital cervix uteri stage group |
| 2.152 NZ AJCC (9th edition) female genital clinical M category |
| 2.153 NZ AJCC (9th edition) female genital clinical N category |
| 2.154 NZ AJCC (9th edition) female genital clinical T category |
| 2.155 NZ AJCC (9th edition) female genital pathological M category |
| 2.156 NZ AJCC (9th edition) female genital pathological N category |
| 2.157 NZ AJCC (9th edition) female genital vulva clinical N category |
| 2.158 NZ AJCC (9th edition) female genital vulva pathological M category |
| 2.159 NZ AJCC (9th edition) female genital vulva pathological N category |
| 2.160 NZ AJCC 8th edition residual tumour category clinical |
| 2.161 NZ AJCC breast clinical M category |
| 2.162 NZ AJCC breast clinical stage group |
| 2.163 NZ AJCC breast clinical T category |
| 2.164 NZ AJCC breast pathological N category |
| 2.165 NZ AJCC breast pathological stage group |
| 2.166 NZ AJCC breast pathological T category |
| 2.167 NZ AJCC breast stage group |
| 2.168 NZ AJCC cancer staging manual edition |
| 2.169 NZ AJCC clinical M category |
| 2.170 NZ AJCC clinical stage group |
| 2.171 NZ AJCC female genital cervix uteri clinical M category |
| 2.172 NZ AJCC female genital cervix uteri clinical T category |
| 2.173 NZ AJCC female genital cervix uteri pathological M category |
| 2.174 NZ AJCC female genital cervix uteri pathological T category |
| 2.175 NZ AJCC female genital cervix uteri stage group |
| 2.176 NZ AJCC female genital clinical T category |
| 2.177 NZ AJCC female genital corpus uteri adenosarcoma clinical N category |
| 2.178 NZ AJCC female genital corpus uteri adenosarcoma pathological T category |
| 2.179 NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma clinical N category |
| 2.180 NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma clinical T category |
| 2.181 NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma pathological T category |
| 2.182 NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma stage group |
| 2.183 NZ AJCC female genital corpus uteri clinical M category |
| 2.184 NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical N category |
| 2.185 NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical T category |
| 2.186 NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma pathological T category |
| 2.187 NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma stage group |
| 2.188 NZ AJCC female genital corpus uteri pathological M category |
| 2.189 NZ AJCC female genital corpus uteri pathological N category |
| 2.190 NZ AJCC female genital corpus uteri pathological T category |
| 2.191 NZ AJCC female genital corpus uteri stage group |
| 2.192 NZ AJCC female genital gestational trophoblastic disease pathological M category |
| 2.193 NZ AJCC female genital gestational trophoblastic disease stage group |
| 2.194 NZ AJCC female genital ovary and fallopian tube and primary peritoneal carcinoma clinical M category |
| 2.195 NZ AJCC female genital ovary and fallopian tube and primary peritoneal carcinoma pathological T category |
| 2.196 NZ AJCC female genital pathological M category |
| 2.197 NZ AJCC female genital vagina clinical N category |
| 2.198 NZ AJCC female genital vagina pathological M category |
| 2.199 NZ AJCC female genital vagina pathological N category |
| 2.200 NZ AJCC female genital vagina pathological T category |
| 2.201 NZ AJCC female genital vagina stage group |
| 2.202 NZ AJCC female genital vulva clinical T category |
| 2.203 NZ AJCC female genital vulva pathological M category |
| 2.204 NZ AJCC female genital vulva pathological N category |
| 2.205 NZ AJCC female genital vulva pathological T category |
| 2.206 NZ AJCC gastrointestinal clinical N category |
| 2.207 NZ AJCC gastrointestinal clinical stage group |
| 2.208 NZ AJCC gastrointestinal colon and rectum clinical M category |
| 2.209 NZ AJCC gastrointestinal colon and rectum clinical N category |
| 2.210 NZ AJCC gastrointestinal colon and rectum clinical T category |
| 2.211 NZ AJCC gastrointestinal colon and rectum pathological N category |
| 2.212 NZ AJCC gastrointestinal colon and rectum stage group |
| 2.213 NZ AJCC gastrointestinal pathological N category |
| 2.214 NZ AJCC gastrointestinal pathological post therapy (neoadjuvant) stage group |
| 2.215 NZ AJCC gastrointestinal stromal tumour clinical M category |
| 2.216 NZ AJCC gastrointestinal stromal tumour clinical N category |
| 2.217 NZ AJCC gastrointestinal stromal tumour clinical T category |
| 2.218 NZ AJCC gastrointestinal stromal tumour pathological M category |
| 2.219 NZ AJCC gastrointestinal stromal tumour pathological N category |
| 2.220 NZ AJCC gastrointestinal stromal tumour small intestine and oesophageal and colon and rectum and mesenteric and peritoneal stage group |
| 2.221 NZ AJCC haematology chronic lymphocytic leukemia or small lymphocytic lymphoma stage group |
| 2.222 NZ AJCC haematology clinical N category |
| 2.223 NZ AJCC haematology cutaneous B cell or T cell non Mycosis fungoides and non-sezary syndrome lymphoma pathological M category |
| 2.224 NZ AJCC haematology Hodgkin or non-Hodgkin lymphoma stage group |
| 2.225 NZ AJCC haematology mycosis fungoides or sezary syndrome clinical M category |
| 2.226 NZ AJCC haematology mycosis fungoides or sezary syndrome clinical N category |
| 2.227 NZ AJCC haematology mycosis fungoides or sezary syndrome clinical T category |
| 2.228 NZ AJCC haematology mycosis fungoides or sezary syndrome pathological M category |
| 2.229 NZ AJCC haematology mycosis fungoides or sezary syndrome pathological N category |
| 2.230 NZ AJCC haematology mycosis fungoides or sezary syndrome pathological T category |
| 2.231 NZ AJCC haematology pathological N category |
| 2.232 NZ AJCC haematology pathological T category |
| 2.233 NZ AJCC haematology pediatric Hodgkin lymphoma stage group |
| 2.234 NZ AJCC haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical M category |
| 2.235 NZ AJCC haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical T category |
| 2.236 NZ AJCC latest edition residual tumour category clinical |
| 2.237 NZ AJCC neuroendocrine gastrointestinal clinical T category |
| 2.238 NZ AJCC neuroendocrine gastrointestinal colon and rectum clinical M category |
| 2.239 NZ AJCC neuroendocrine gastrointestinal colon and rectum pathological T category |
| 2.240 NZ AJCC neuroendocrine gastrointestinal colon and rectum stage group |
| 2.241 NZ AJCC neuroendocrine gastrointestinal pathological M category |
| 2.242 NZ AJCC neuroendocrine gastrointestinal pathological N category |
| 2.243 NZ AJCC neuroendocrine gastrointestinal stage group |
| 2.244 NZ AJCC pathological M category |
| 2.245 NZ AJCC pathological stage group |
| 2.246 NZ AJCC pathological T category |
| 2.247 NZ AJCC post therapy (neoadjuvant) pathological N category (ypN) |
| 2.248 NZ AJCC recurrence or retreatment clinical N category (rcN) |
| 2.249 NZ AJCC recurrence or retreatment pathological N category (rpN) |
| 2.250 NZ AJCC staging chapter |
| 2.251 NZ AJCC thoracic clinical N category |
| 2.252 NZ AJCC thoracic clinical T category |
| 2.253 NZ AJCC thoracic lung clinical M category |
| 2.254 NZ AJCC thoracic lung clinical N category |
| 2.255 NZ AJCC thoracic lung stage group |
| 2.256 NZ AJCC thoracic malignant pleural mesothelioma clinical N category |
| 2.257 NZ AJCC thoracic malignant pleural mesothelioma pathological M category |
| 2.258 NZ AJCC thoracic malignant pleural mesothelioma pathological N category |
| 2.259 NZ AJCC thoracic malignant pleural mesothelioma pathological T category |
| 2.260 NZ AJCC thoracic malignant pleural mesothelioma stage group |
| 2.261 NZ AJCC thoracic pathological N category |
| 2.262 NZ AJCC thoracic stage group |
| 2.263 NZ AJCC thoracic thymus clinical M category |
| 2.264 NZ AJCC thoracic thymus clinical N category |
| 2.265 NZ AJCC thoracic thymus clinical T category |
| 2.266 NZ AJCC thoracic thymus pathological T category |
| 2.267 NZ AJCC thoracic thymus stage group |
| 2.268 NZ cancer acute leukaemia cancer type |
| 2.269 NZ cancer adrenal topography |
| 2.270 NZ cancer aggressive B cell lymphoma cancer type |
| 2.271 NZ cancer aggressive non-Hodgkin B cell lymphoma cancer type |
| 2.272 NZ cancer Ann Arbor lymphoma stage |
| 2.273 NZ cancer B cell lymphoid cancer type |
| 2.274 NZ cancer B cell lymphoid substream |
| 2.275 NZ cancer B cell lymphoma cancer type |
| 2.276 NZ cancer basis of diagnosis |
| 2.277 NZ cancer BL-IPI prognostic score |
| 2.278 NZ cancer bone cancer type |
| 2.279 NZ cancer bone other topography |
| 2.280 NZ cancer bone pelvis topography |
| 2.281 NZ cancer bone thoracic topography |
| 2.282 NZ cancer bone vertebral column topography |
| 2.283 NZ cancer breast ancillary studies |
| 2.284 NZ cancer breast clinical behaviour category |
| 2.285 NZ cancer breast clinical presentation |
| 2.286 NZ cancer breast lymph node |
| 2.287 NZ cancer breast mammogram finding |
| 2.288 NZ cancer breast non-nipple-areola complex topography |
| 2.289 NZ cancer breast procedure image guided method |
| 2.290 NZ cancer breast radiology type |
| 2.291 NZ cancer breast related topography |
| 2.292 NZ cancer breast resection procedure type |
| 2.293 NZ cancer breast ultrasound finding |
| 2.294 NZ cancer central nervous system brain topography |
| 2.295 NZ cancer central nervous system meninges topography |
| 2.296 NZ cancer central nervous system nerve topography |
| 2.297 NZ cancer central nervous system other topography |
| 2.298 NZ cancer central nervous system topography |
| 2.299 NZ cancer clinical assessment scale |
| 2.300 NZ cancer clinical impression of behaviour |
| 2.301 NZ cancer clockface position |
| 2.302 NZ cancer CNS cancer type |
| 2.303 NZ cancer CNS melanoma topography |
| 2.304 NZ cancer CNS status in acute lymphoblastic leukaemia lymphoma prognostic score |
| 2.305 NZ cancer CNS-IPI for large B cell lymphoma prognostic score |
| 2.306 NZ cancer colonoscopy topography |
| 2.307 NZ cancer colorectal cancer type |
| 2.308 NZ cancer colorectal metastectomy topography subtype |
| 2.309 NZ cancer colorectal screening colonoscopy specimen type |
| 2.310 NZ cancer colorectal surveillance colonoscopy referral criteria |
| 2.311 NZ cancer data absent reason |
| 2.312 NZ cancer diagnosis clinical status |
| 2.313 NZ cancer document type |
| 2.314 NZ cancer ELN standardised reporting for genetic alteration in AML prognostic score |
| 2.315 NZ cancer endocrine and neuroendocrine cancer type |
| 2.316 NZ cancer endocrine and neuroendocrine substream |
| 2.317 NZ cancer endocrine and/or neuroendocrine topography |
| 2.318 NZ cancer endocrine other topography |
| 2.319 NZ cancer endocrine topography |
| 2.320 NZ cancer ER expression |
| 2.321 NZ cancer EUTOS for CML prognostic score |
| 2.322 NZ cancer excision specimen type |
| 2.323 NZ cancer eye and orbit cancer type |
| 2.324 NZ cancer eye and orbit lacrimal drainage system topography |
| 2.325 NZ cancer eye and orbit lacrimal gland topography |
| 2.326 NZ cancer eye and orbit lymph node |
| 2.327 NZ cancer eye and orbit optic nerve topography |
| 2.328 NZ cancer eye and orbit other topography |
| 2.329 NZ cancer eye and orbit uveal tract topography |
| 2.330 NZ cancer female genital cervix uteri lymph node |
| 2.331 NZ cancer female genital cervix uteri topography |
| 2.332 NZ cancer female genital corpus uteri lymph node |
| 2.333 NZ cancer female genital corpus uteri topography |
| 2.334 NZ cancer female genital fallopian tube topography |
| 2.335 NZ cancer female genital gestational trophoblastic disease topography |
| 2.336 NZ cancer female genital peritoneum topography |
| 2.337 NZ cancer female genital uterine ligament topography |
| 2.338 NZ cancer female genital vulva lymph node |
| 2.339 NZ cancer female genital vulva topography |
| 2.340 NZ cancer FIGO 2001 gestational trophoblastic disease stage |
| 2.341 NZ cancer FIGO 2009 endometrial carcinoma stage |
| 2.342 NZ cancer FIGO 2015 corpus uteri adenosarcoma stage |
| 2.343 NZ cancer FIGO 2018 cervix uteri stage |
| 2.344 NZ cancer FIGO 2021 vulva stage |
| 2.345 NZ cancer FLIPI prognostic score |
| 2.346 NZ cancer follicular lymphoma grade |
| 2.347 NZ cancer frozen section specimen type |
| 2.348 NZ cancer gastroenteropancreatic neuroendocrine tumour anal topography |
| 2.349 NZ cancer gastroenteropancreatic neuroendocrine tumour appendix topography |
| 2.350 NZ cancer gastroenteropancreatic neuroendocrine tumour colorectal topography |
| 2.351 NZ cancer gastroenteropancreatic neuroendocrine tumour other topography |
| 2.352 NZ cancer gastroenteropancreatic neuroendocrine tumour pancreas topography |
| 2.353 NZ cancer gastroenteropancreatic neuroendocrine tumour stomach topography |
| 2.354 NZ cancer gastroenteropancreatic neuroendocrine tumour topography |
| 2.355 NZ cancer gastrointestinal anus lymph node |
| 2.356 NZ cancer gastrointestinal cancer type |
| 2.357 NZ cancer gastrointestinal colon topography |
| 2.358 NZ cancer gastrointestinal colorectal lymph node |
| 2.359 NZ cancer gastrointestinal colorectal metastecomy resection specimen collection procedure |
| 2.360 NZ cancer gastrointestinal colorectal resection topography |
| 2.361 NZ cancer gastrointestinal colorectal topography |
| 2.362 NZ cancer gastrointestinal diagnostic specimen collection procedure |
| 2.363 NZ cancer gastrointestinal duodenum topography |
| 2.364 NZ cancer gastrointestinal exocrine pancreas topography |
| 2.365 NZ cancer gastrointestinal hepatopancreaticobiliary topography |
| 2.366 NZ cancer gastrointestinal ileum and jejunum topography |
| 2.367 NZ cancer gastrointestinal liver topography |
| 2.368 NZ cancer gastrointestinal lymph node |
| 2.369 NZ cancer gastrointestinal oesophagus topography |
| 2.370 NZ cancer gastrointestinal pancreas topography |
| 2.371 NZ cancer gastrointestinal rectum topography |
| 2.372 NZ cancer gastrointestinal specimen collection procedure |
| 2.373 NZ cancer gastrointestinal stomach lymph node |
| 2.374 NZ cancer gastrointestinal stomach topography |
| 2.375 NZ cancer gastrointestinal substream |
| 2.376 NZ cancer genitourinary (non prostate) cancer type |
| 2.377 NZ cancer genitourinary substream |
| 2.378 NZ cancer GHSG Hodgkin treatment stratification stage |
| 2.379 NZ cancer grade |
| 2.380 NZ cancer grading system |
| 2.381 NZ cancer haematology stream |
| 2.382 NZ cancer haematology substream |
| 2.383 NZ cancer haematology treatment intent |
| 2.384 NZ cancer head and neck cancer type |
| 2.385 NZ cancer head and neck hypopharynx topography |
| 2.386 NZ cancer head and neck larynx topography |
| 2.387 NZ cancer head and neck lymph node |
| 2.388 NZ cancer head and neck major salivary gland topography |
| 2.389 NZ cancer head and neck nasal cavity and paranasal sinus topography |
| 2.390 NZ cancer head and neck nasal topography |
| 2.391 NZ cancer head and neck nasopharynx topography |
| 2.392 NZ cancer head and neck odontogenic topography |
| 2.393 NZ cancer head and neck other topography |
| 2.394 NZ cancer head and neck substream |
| 2.395 NZ cancer head and neck with thyroid topography |
| 2.396 NZ cancer health worker role pathologist radiologist surgeon |
| 2.397 NZ cancer heamatology recurrence type |
| 2.398 NZ cancer high level topography |
| 2.399 NZ cancer Hodgkin lymphoma International Prognostic Score |
| 2.400 NZ cancer indolent B cell lymphoma cancer type |
| 2.401 NZ cancer indolent non-Hodgkin B cell lymphoma cancer type |
| 2.402 NZ cancer IPSS-R for MDS prognostic score |
| 2.403 NZ cancer laboratory test method |
| 2.404 NZ cancer laterality |
| 2.405 NZ cancer laterality mandatory |
| 2.406 NZ cancer laterality optional |
| 2.407 NZ cancer laterality or side |
| 2.408 NZ cancer laterality or side mandatory |
| 2.409 NZ cancer laterality with unknown value |
| 2.410 NZ cancer lower gastrointestinal cancer type |
| 2.411 NZ cancer Lugano staging classification for lymphoma |
| 2.412 NZ cancer lymph node specimen type |
| 2.413 NZ cancer lymphoma substream |
| 2.414 NZ cancer male genital lymph node |
| 2.415 NZ cancer male genital SACT cancer type |
| 2.416 NZ cancer male genital topography |
| 2.417 NZ cancer MALT-IPI prognostic score |
| 2.418 NZ cancer mastocytosis cancer type |
| 2.419 NZ cancer MD Anderson residual cancer burden |
| 2.420 NZ cancer medical oncology cns cancer type |
| 2.421 NZ cancer medical oncology endocrine cancer type |
| 2.422 NZ cancer medical oncology genitourinary cancer type |
| 2.423 NZ cancer medical oncology gynaecological cancer type |
| 2.424 NZ cancer medical oncology head and neck cancer type |
| 2.425 NZ cancer medical oncology head and neck other topography |
| 2.426 NZ cancer medical oncology male genital topography |
| 2.427 NZ cancer medical oncology other head and neck cancer type |
| 2.428 NZ cancer medical oncology skin and/or melanoma topography |
| 2.429 NZ cancer medical oncology skin topography |
| 2.430 NZ cancer medical oncology solid tumour cancer type |
| 2.431 NZ cancer medical oncology solid tumour substream |
| 2.432 NZ cancer medical oncology thoracic cancer type |
| 2.433 NZ cancer medical oncology treatment intent |
| 2.434 NZ cancer medical oncology urinary and male genital testicular topography |
| 2.435 NZ cancer medical oncology urinary and male genital topography |
| 2.436 NZ cancer medicial oncology thoracic substream |
| 2.437 NZ cancer melanoma cancer type |
| 2.438 NZ cancer menopause status |
| 2.439 NZ cancer midline non-symmetrical topography |
| 2.440 NZ cancer midline topography |
| 2.441 NZ cancer MIPI prognostic score |
| 2.442 NZ cancer MIPSS 70+ v2.0 myelofibrosis prognostic score |
| 2.443 NZ cancer myelodysplastic-myeloproliferative cancer type |
| 2.444 NZ cancer myeloid proliferation and myeloid neoplasm cancer type |
| 2.445 NZ cancer nail topography |
| 2.446 NZ cancer nasal cavity and paranasal sinus cancer type |
| 2.447 NZ cancer national cervical screening programme benign and reactive diagnosis |
| 2.448 NZ cancer national cervical screening programme completeness of excision |
| 2.449 NZ cancer national cervical screening programme specimen type |
| 2.450 NZ cancer national cervical screening programme topography |
| 2.451 NZ cancer neoadjuvant therapy administration type (non-hormone) |
| 2.452 NZ cancer neoadjuvant therapy response system |
| 2.453 NZ cancer neuroendocrine GEP cancer type |
| 2.454 NZ cancer neuroendocrine non GEP cancer type |
| 2.455 NZ cancer neuroendocrine substream |
| 2.456 NZ cancer neuroendocrine tumour breast topography |
| 2.457 NZ cancer neuroendocrine tumour male genital topography |
| 2.458 NZ cancer neuroendocrine tumour urinary topography |
| 2.459 NZ cancer non Hodgkin lymphoma cancer type |
| 2.460 NZ cancer non-AJCC staging system |
| 2.461 NZ cancer not performed reason |
| 2.462 NZ cancer nuclear grade of DCIS grade |
| 2.463 NZ cancer observation code |
| 2.464 NZ cancer other gastrointestinal hepatopancreaticobiliary topography |
| 2.465 NZ cancer parathryoid topography |
| 2.466 NZ cancer PCR OR NGS test method |
| 2.467 NZ cancer PERCIST 1.0 cancer burden |
| 2.468 NZ cancer performance status |
| 2.469 NZ cancer pharynx and larynx and trachea cancer type |
| 2.470 NZ cancer PIT prognostic score |
| 2.471 NZ cancer pituitary neuroendocrine tumour topography |
| 2.472 NZ cancer polyp morphology specimen type |
| 2.473 NZ cancer polyp profile type |
| 2.474 NZ cancer positive negative result |
| 2.475 NZ cancer presence of tumour finding |
| 2.476 NZ cancer procedure referral criteria assessment |
| 2.477 NZ cancer procedure status |
| 2.478 NZ cancer prognostic scoring system |
| 2.479 NZ cancer R-ISS for multiple myeloma stage |
| 2.480 NZ cancer radiation oncology beam energy type |
| 2.481 NZ cancer radiation oncology planning technique |
| 2.482 NZ cancer radiology type |
| 2.483 NZ cancer Rai staging for CLL stage |
| 2.484 NZ cancer RECIST 1.1 cancer burden |
| 2.485 NZ cancer recurrence type |
| 2.486 NZ cancer revised Mayo staging 2012 for AL (amyloidosis) stage |
| 2.487 NZ cancer revised TNM-B staging for cutaneous T cell lymphoma stage |
| 2.488 NZ cancer service |
| 2.489 NZ cancer side |
| 2.490 NZ cancer side mandatory |
| 2.491 NZ cancer simple performance status |
| 2.492 NZ cancer skin and melanoma substream |
| 2.493 NZ cancer skin cancer type |
| 2.494 NZ cancer skin of extremity topography |
| 2.495 NZ cancer skin of head and neck topography |
| 2.496 NZ cancer skin of trunk topography |
| 2.497 NZ cancer skin topography |
| 2.498 NZ cancer soft tissue abdomen and pelvis topography |
| 2.499 NZ cancer soft tissue and bone cancer type |
| 2.500 NZ cancer soft tissue and bone substream |
| 2.501 NZ cancer soft tissue extremity topography |
| 2.502 NZ cancer soft tissue head and neck topography |
| 2.503 NZ cancer soft tissue skin topography |
| 2.504 NZ cancer soft tissue thoracic topography |
| 2.505 NZ cancer solid tumour non-AJCC staging system |
| 2.506 NZ cancer solid tumour SACT cancer type |
| 2.507 NZ cancer solid tumour staging system |
| 2.508 NZ cancer solid tumour substream |
| 2.509 NZ cancer specimen category |
| 2.510 NZ cancer specimen category biopsy or excision |
| 2.511 NZ cancer specimen dimension type |
| 2.512 NZ cancer stage classification |
| 2.513 NZ cancer stream |
| 2.514 NZ cancer surgical margin qualifier proximal or distal |
| 2.515 NZ cancer surgical margin type |
| 2.516 NZ cancer T/NK cell lymphoma cancer type |
| 2.517 NZ cancer test failure reason |
| 2.518 NZ cancer test inconclusive reason |
| 2.519 NZ cancer thoracic cancer type |
| 2.520 NZ cancer thorax lung lobe topography |
| 2.521 NZ cancer thorax lung lymph node |
| 2.522 NZ cancer thorax lymph node |
| 2.523 NZ cancer thorax medical oncology mesothelioma topography |
| 2.524 NZ cancer thorax medical oncology topography |
| 2.525 NZ cancer thorax soft tissue topography |
| 2.526 NZ cancer thorax thymus topography |
| 2.527 NZ cancer thorax topography |
| 2.528 NZ cancer thryoid topography |
| 2.529 NZ cancer thyroid topography |
| 2.530 NZ cancer treatment intent |
| 2.531 NZ cancer tumour focality |
| 2.532 NZ cancer tumour origin |
| 2.533 NZ cancer unknown site topography |
| 2.534 NZ cancer upper gastrointestinal cancer type |
| 2.535 NZ cancer upper gastrointestinal topography |
| 2.536 NZ cancer urinary and male genital kidney lymph node |
| 2.537 NZ cancer urinary and male genital kidney topography |
| 2.538 NZ cancer urinary and male genital lymph node |
| 2.539 NZ cancer urinary and male genital penis lymph node |
| 2.540 NZ cancer urinary and male genital prostate topography |
| 2.541 NZ cancer urinary and male genital renal pelvis and ureter lymph node |
| 2.542 NZ cancer urinary and male genital renal pelvis and ureter topography |
| 2.543 NZ cancer urinary and male genital renal pelvis lymph node |
| 2.544 NZ cancer urinary and male genital testicular adnexa topography |
| 2.545 NZ cancer urinary and male genital testicular topography |
| 2.546 NZ cancer urinary and male genital testis lymph node |
| 2.547 NZ cancer urinary and male genital testis topography |
| 2.548 NZ cancer urinary and male genital urinary bladder lymph node |
| 2.549 NZ cancer urinary and male genital urinary bladder topography |
| 2.550 NZ cancer urinary system cancer type |
| 2.551 NZ cancer urinary system lymph node |
| 2.552 NZ cancer urinary system topography |
| 2.553 NZ clinical TNM stage classification |
| 2.554 NZ colorectal obstruction or perforation present in colon |
| 2.555 NZ colorectal obstruction present |
| 2.556 NZ colorectal perforation present |
| 2.557 NZ ethnic group code level 1 |
| 2.558 NZ lung cancer type |
| 2.559 NZ medical oncology cancer endocrine and neuroendocrine cancer type |
| 2.560 NZ medical oncology WHO brain primary histology |
| 2.561 NZ Nottingham Combined grade |
| 2.562 NZ perforation present in colon |
| 2.563 NZ SACT acute myeloid leukemia disease response |
| 2.564 NZ SACT amyloidosis disease response |
| 2.565 NZ SACT cancer type |
| 2.566 NZ SACT chronic lymphocytic leukemia and small lymphocytic lymphoma disease response |
| 2.567 NZ SACT chronic myeloid leukemia disease response |
| 2.568 NZ SACT dose form |
| 2.569 NZ SACT dose unit |
| 2.570 NZ SACT ECOG status |
| 2.571 NZ SACT haematology disease response |
| 2.572 NZ SACT heamatology disease response |
| 2.573 NZ SACT lymphoma (non small lymphocytic) disease response |
| 2.574 NZ SACT medical oncology disease response |
| 2.575 NZ SACT myelodysplastic syndrome disease response |
| 2.576 NZ SACT overall discontinue reason |
| 2.577 NZ SACT patient factor discontinue |
| 2.578 NZ SACT PR expression |
| 2.579 NZ surgical intent |
| 2.580 NZ systemic anti-cancer therapy toxicity discontinue reason |
| 2.581 NZ systemtic anti-cancer therapy substream |
| 2.582 NZ TNM stage classification |
| 2.583 NZ TNM suffix |
| 2.584 NZ WHO (5th edition) malignant differentiation grade |
| 2.585 NZ WHO (5th edition) malignant low high (differentiation) grade |
| 2.586 NZ WHO (5th edition) thoracic neuroendocrine tumour grade |
| 2.587 NZ WHO anus primary histology |
| 2.588 NZ WHO appendix site histology |
| 2.589 NZ WHO bone haematolymphoid histology |
| 2.590 NZ WHO bone histology |
| 2.591 NZ WHO bone histology (5th edition) |
| 2.592 NZ WHO brain primary histology |
| 2.593 NZ WHO brain site histology |
| 2.594 NZ WHO breast behaviour free histology (5th edition) |
| 2.595 NZ WHO breast benign histology (5th edition) |
| 2.596 NZ WHO breast ductal carcinoma in situ histology |
| 2.597 NZ WHO breast haematolymphoid histology |
| 2.598 NZ WHO breast haematolymphoid histology (5th edition) |
| 2.599 NZ WHO breast histology (5th edition) |
| 2.600 NZ WHO breast invasive carcinoma histology |
| 2.601 NZ WHO breast invasive histology |
| 2.602 NZ WHO breast primary histology |
| 2.603 NZ WHO breast tumour of nipple histology |
| 2.604 NZ WHO breast tumour of nipple histology (5th edition) |
| 2.605 NZ WHO breast uncertain and borderline histology |
| 2.606 NZ WHO central nervous system choroid plexus histology (5th edition) |
| 2.607 NZ WHO central nervous system cranial and paraspinal nerve histology |
| 2.608 NZ WHO central nervous system cranial and paraspinal nerve histology (5th edition) |
| 2.609 NZ WHO central nervous system embryonal histology (5th edition) |
| 2.610 NZ WHO central nervous system germ cell histology (5th edition) |
| 2.611 NZ WHO central nervous system glioma and glioneuronal and neuronal histology (5th edition) |
| 2.612 NZ WHO central nervous system haematolymphoid histology |
| 2.613 NZ WHO central nervous system haematolymphoid histology (5th edition) |
| 2.614 NZ WHO central nervous system melanocytic histology |
| 2.615 NZ WHO central nervous system meningioma histology |
| 2.616 NZ WHO central nervous system pineal histology |
| 2.617 NZ WHO central nervous system pineal histology (5th edition) |
| 2.618 NZ WHO central nervous system sellar region histology |
| 2.619 NZ WHO central nervous system sellar region histology (5th edition) |
| 2.620 NZ WHO central nervous system tumour grade reference set |
| 2.621 NZ WHO classification of CNS melanoma primary histology |
| 2.622 NZ WHO classification of melanoma primary histology |
| 2.623 NZ WHO classification of Merkel cell carcinoma primary histology |
| 2.624 NZ WHO classification of squamous cell carcinoma primary histology |
| 2.625 NZ WHO classification of tumours (5th edition) CNS melanoma histology |
| 2.626 NZ WHO classification of tumours (5th edition) haematolymphoid intestinal T-cell and natural killer cell lymphoid proliferation histology reference set |
| 2.627 NZ WHO classification of tumours (5th edition) haematolymphoid secondary myeloid neoplasm histology |
| 2.628 NZ WHO classification of tumours (5th edition) head and neck benign histology |
| 2.629 NZ WHO classification of tumours (5th edition) head and neck ear histology |
| 2.630 NZ WHO classification of tumours (5th edition) head and neck haematolymphoid histology |
| 2.631 NZ WHO classification of tumours (5th edition) head and neck histology |
| 2.632 NZ WHO classification of tumours (5th edition) head and neck hypopharynx and larynx and trachea and parapharyngeal histology |
| 2.633 NZ WHO classification of tumours (5th edition) head and neck malignant histology |
| 2.634 NZ WHO classification of tumours (5th edition) head and neck melanocytic histology |
| 2.635 NZ WHO classification of tumours (5th edition) head and neck nasal and paranasal and skull base histology |
| 2.636 NZ WHO classification of tumours (5th edition) head and neck nasopharynx histology |
| 2.637 NZ WHO classification of tumours (5th edition) head and neck odontogenic and maxillofacial bone histology |
| 2.638 NZ WHO classification of tumours (5th edition) head and neck oral cavity and mobile tongue histology |
| 2.639 NZ WHO classification of tumours (5th edition) head and neck precursor histology |
| 2.640 NZ WHO classification of tumours (5th edition) head and neck salivary gland histology |
| 2.641 NZ WHO classification of tumours (5th edition) head and neck soft tissue histology |
| 2.642 NZ WHO classification of tumours (5th edition) head and neck tumour and tumour-like lesion of the neck and lymph node histology |
| 2.643 NZ WHO classification of tumours (5th edition) melanoma histology |
| 2.644 NZ WHO classification of tumours (5th edition) Merkel cell carcinoma histology |
| 2.645 NZ WHO classification of tumours (5th edition) mucosal melanoma histology |
| 2.646 NZ WHO classification of tumours (5th edition) skin haematolymphoid histology |
| 2.647 NZ WHO classification of tumours (5th edition) skin histology |
| 2.648 NZ WHO classification of tumours (5th edition) skin keratinocytic and epidermal histology |
| 2.649 NZ WHO classification of tumours (5th edition) skin precursor histology |
| 2.650 NZ WHO classification of tumours (5th edition) skin soft tissue histology |
| 2.651 NZ WHO classification of tumours haematolymphoid intestinal T-cell and natural killer cell lymphoid proliferation histology reference set |
| 2.652 NZ WHO classification of tumours haematolymphoid secondary myeloid neoplasm histology |
| 2.653 NZ WHO classification of tumours head and neck benign histology |
| 2.654 NZ WHO classification of tumours head and neck ear histology |
| 2.655 NZ WHO classification of tumours head and neck germ cell tumour histology |
| 2.656 NZ WHO classification of tumours head and neck haematolymphoid histology |
| 2.657 NZ WHO classification of tumours head and neck hypopharynx and larynx and trachea and parapharyngeal histology |
| 2.658 NZ WHO classification of tumours head and neck hypopharynx and larynx and trachea and parapharyngeal primary histology |
| 2.659 NZ WHO classification of tumours head and neck hypopharynx and larynx and trachea and parapharyngeal site histology |
| 2.660 NZ WHO classification of tumours head and neck malignant histology |
| 2.661 NZ WHO classification of tumours head and neck melanocytic histology |
| 2.662 NZ WHO classification of tumours head and neck nasal and paranasal and skull base histology |
| 2.663 NZ WHO classification of tumours head and neck nasal and paranasal and skull base primary histology |
| 2.664 NZ WHO classification of tumours head and neck nasal and paranasal and skull base site histology |
| 2.665 NZ WHO classification of tumours head and neck nasal primary histology |
| 2.666 NZ WHO classification of tumours head and neck nasal site histology |
| 2.667 NZ WHO classification of tumours head and neck nasopharynx histology |
| 2.668 NZ WHO classification of tumours head and neck nasopharynx site histology |
| 2.669 NZ WHO classification of tumours head and neck neuroendocrine neoplasm and paraganglioma histology |
| 2.670 NZ WHO classification of tumours head and neck odontogenic and maxillofacial bone histology |
| 2.671 NZ WHO classification of tumours head and neck odontogenic and maxillofacial bone primary histology |
| 2.672 NZ WHO classification of tumours head and neck oral cavity and mobile tongue histology |
| 2.673 NZ WHO classification of tumours head and neck oral cavity and mobile tongue primary histology |
| 2.674 NZ WHO classification of tumours head and neck oropharynx histology |
| 2.675 NZ WHO classification of tumours head and neck oropharynx primary histology |
| 2.676 NZ WHO classification of tumours head and neck pharynx and larynx and trachea primary histology |
| 2.677 NZ WHO classification of tumours head and neck pharynx and larynx and trachea site histology |
| 2.678 NZ WHO classification of tumours head and neck salivary gland histology |
| 2.679 NZ WHO classification of tumours head and neck salivary gland primary histology |
| 2.680 NZ WHO classification of tumours head and neck salivary gland site histology |
| 2.681 NZ WHO classification of tumours head and neck soft tissue histology |
| 2.682 NZ WHO classification of tumours head and neck uncertain behaviour histology |
| 2.683 NZ WHO classification of tumours skin haematolymphoid histology |
| 2.684 NZ WHO classification of tumours skin keratinocytic and epidermal histology |
| 2.685 NZ WHO classification of tumours skin malignant histology |
| 2.686 NZ WHO classification of tumours skin melanocytic neoplasm histology |
| 2.687 NZ WHO classification of tumours skin precursor histology |
| 2.688 NZ WHO colorectal primary histology |
| 2.689 NZ WHO colorectal site histology |
| 2.690 NZ WHO conjunctiva primary histology |
| 2.691 NZ WHO digestive system anal canal histology (5th edition) |
| 2.692 NZ WHO digestive system appendix histology |
| 2.693 NZ WHO digestive system appendix histology (5th edition) |
| 2.694 NZ WHO digestive system benign tumour histology (5th edition) |
| 2.695 NZ WHO digestive system colon and rectum histology |
| 2.696 NZ WHO digestive system colon and rectum hormone producing tumor histology (5th edition) |
| 2.697 NZ WHO digestive system germ cell tumour histology (5th edition) |
| 2.698 NZ WHO digestive system haematolymphoid histology (5th edition) |
| 2.699 NZ WHO digestive system liver and intrahepatic bile duct histology (5th edition) |
| 2.700 NZ WHO digestive system malignant tumour histology |
| 2.701 NZ WHO digestive system mesenchymal histology |
| 2.702 NZ WHO digestive system mesenchymal histology (5th edition) |
| 2.703 NZ WHO digestive system oesophagus histology |
| 2.704 NZ WHO digestive system precursor tumour histology (5th edition) |
| 2.705 NZ WHO digestive system uncertain behaviour tumour histology |
| 2.706 NZ WHO digestive system uncertain behaviour tumour histology (5th edition) |
| 2.707 NZ WHO endocrine and neuroendocrine adrenal cortex primary histology |
| 2.708 NZ WHO endocrine and neuroendocrine adrenal cortex site histology |
| 2.709 NZ WHO endocrine and neuroendocrine adrenal gland histology |
| 2.710 NZ WHO endocrine and neuroendocrine adrenal gland histology (5th edition) |
| 2.711 NZ WHO endocrine and neuroendocrine adrenal gland including adrenal medulla primary histology |
| 2.712 NZ WHO endocrine and neuroendocrine adrenal gland including adrenal medulla site histology |
| 2.713 NZ WHO endocrine and neuroendocrine adrenal medulla primary histology |
| 2.714 NZ WHO endocrine and neuroendocrine benign histology (5th edition) |
| 2.715 NZ WHO endocrine and neuroendocrine germ cell histology |
| 2.716 NZ WHO endocrine and neuroendocrine malignant histology |
| 2.717 NZ WHO endocrine and neuroendocrine malignant histology (5th edition) |
| 2.718 NZ WHO endocrine and neuroendocrine paraganglioma primary histology |
| 2.719 NZ WHO endocrine and neuroendocrine parathyroid gland primary histology |
| 2.720 NZ WHO endocrine and neuroendocrine parathyroid gland site histology |
| 2.721 NZ WHO endocrine and neuroendocrine pituitary gland histology |
| 2.722 NZ WHO endocrine and neuroendocrine pituitary gland histology (5th edition) |
| 2.723 NZ WHO endocrine and neuroendocrine pituitary gland primary histology |
| 2.724 NZ WHO endocrine and neuroendocrine thyroid gland histology |
| 2.725 NZ WHO endocrine and neuroendocrine thyroid gland histology (5th edition) |
| 2.726 NZ WHO endocrine and neuroendocrine thyroid gland primary histology |
| 2.727 NZ WHO endocrine and neuroendocrine uncertain behaviour histology |
| 2.728 NZ WHO endocrine and neuroendocrine uncertain behaviour histology (5th edition) |
| 2.729 NZ WHO endocrine primary histology |
| 2.730 NZ WHO eye and orbit behaviour free histology |
| 2.731 NZ WHO eye and orbit eyelid histology |
| 2.732 NZ WHO eye and orbit haematolymphoid histology |
| 2.733 NZ WHO eye and orbit haematolymphoid histology (5th edition) |
| 2.734 NZ WHO eye and orbit histology (5th edition) |
| 2.735 NZ WHO eye and orbit in situ histology |
| 2.736 NZ WHO eye and orbit lacrimal gland histology |
| 2.737 NZ WHO eye and orbit lacrimal gland histology (5th edition) |
| 2.738 NZ WHO eye and orbit optic disc and optic nerve histology |
| 2.739 NZ WHO eye and orbit optic disc and optic nerve histology (5th edition) |
| 2.740 NZ WHO eye and orbit retina and neuroepithelium histology (5th edition) |
| 2.741 NZ WHO eye and orbit soft tissue and bone histology (5th edition) |
| 2.742 NZ WHO eye and orbit uncertain and borderline histology (5th edition) |
| 2.743 NZ WHO eye and orbit uveal tract histology |
| 2.744 NZ WHO eyelid site histology |
| 2.745 NZ WHO fallopian tube primary histology |
| 2.746 NZ WHO female breast primary (no nipple) histology |
| 2.747 NZ WHO female genital germ cell histology (5th edition) |
| 2.748 NZ WHO female genital gestational trophoblastic disease histology |
| 2.749 NZ WHO female genital haematolymphoid histology |
| 2.750 NZ WHO female genital haematolymphoid histology (5th edition) |
| 2.751 NZ WHO female genital histology |
| 2.752 NZ WHO female genital melanocytic lesion histology |
| 2.753 NZ WHO female genital mesenchymal tumour of lower genital tract histology |
| 2.754 NZ WHO female genital neuroendocrine histology |
| 2.755 NZ WHO female genital neuroendocrine histology (5th edition) |
| 2.756 NZ WHO female genital ovary histology |
| 2.757 NZ WHO female genital ovary histology (5th edition) |
| 2.758 NZ WHO female genital peritoneum histology |
| 2.759 NZ WHO female genital peritoneum histology (5th edition) |
| 2.760 NZ WHO female genital uterine ligament histology |
| 2.761 NZ WHO female genital vagina histology |
| 2.762 NZ WHO female genital vagina histology (5th edition) |
| 2.763 NZ WHO female genital vulva histology |
| 2.764 NZ WHO gestational trophoblastic site histology |
| 2.765 NZ WHO haematology chronic myeloproliferative neoplasm histology |
| 2.766 NZ WHO haematology chronic myeloproliferative neoplasm histology (5th edition) |
| 2.767 NZ WHO haematolymphoid acute leukaemia of mixed or ambiguous lineage histology (5th edition) |
| 2.768 NZ WHO haematolymphoid acute lymphoblastic leukaemia histology |
| 2.769 NZ WHO haematolymphoid aggressive cell lymphoma histology (5th edition) |
| 2.770 NZ WHO haematolymphoid aggressive non-hodgkin B cell lymphoma histology |
| 2.771 NZ WHO haematolymphoid aggressive non-Hodgkin B cell lymphoma histology (5th edition) |
| 2.772 NZ WHO haematolymphoid amyloidosis histology (5th edition) |
| 2.773 NZ WHO haematolymphoid B cell lymphoid neoplasm histology |
| 2.774 NZ WHO haematolymphoid B cell lymphoma histology |
| 2.775 NZ WHO haematolymphoid B cell lymphoma histology (5th edition) |
| 2.776 NZ WHO haematolymphoid B lymphoblastic leukaemia lymphoma histology |
| 2.777 NZ WHO haematolymphoid Burkitt lymphoma histology |
| 2.778 NZ WHO haematolymphoid Burkitt lymphoma histology (5th edition) |
| 2.779 NZ WHO haematolymphoid Castleman disease histology |
| 2.780 NZ WHO haematolymphoid Castleman disease histology (5th edition) |
| 2.781 NZ WHO haematolymphoid chronic leukaemia histology |
| 2.782 NZ WHO haematolymphoid chronic lymphocytic leukaemia histology |
| 2.783 NZ WHO haematolymphoid chronic lymphocytic leukaemia histology (5th edition) |
| 2.784 NZ WHO haematolymphoid chronic myeloid leukaemia histology (5th edition) |
| 2.785 NZ WHO haematolymphoid chronic myelomonocytic leukaemia histology |
| 2.786 NZ WHO haematolymphoid chronic neutrophilic leukaemia histology |
| 2.787 NZ WHO haematolymphoid essential thrombocythaemia histology |
| 2.788 NZ WHO haematolymphoid essential thrombocythaemia histology (5th edition) |
| 2.789 NZ WHO haematolymphoid extranodal NK/T cell lymphoid proliferation histology |
| 2.790 NZ WHO haematolymphoid extranodal NK/T cell lymphoma histology |
| 2.791 NZ WHO haematolymphoid extranodal NK/T cell lymphoma histology (5th edition) |
| 2.792 NZ WHO haematolymphoid hairy cell leukaemia histology |
| 2.793 NZ WHO haematolymphoid histiocytic dendritic cell neoplasm histology (5th edition) |
| 2.794 NZ WHO haematolymphoid histiocytic dendritic cell neoplasm other histology |
| 2.795 NZ WHO haematolymphoid indolent B cell lymphoma histology |
| 2.796 NZ WHO haematolymphoid indolent B cell lymphoma histology (5th edition) |
| 2.797 NZ WHO haematolymphoid indolent B cell lymphoma other histology |
| 2.798 NZ WHO haematolymphoid indolent non-Hodgkin B cell lymphoma histology (5th edition) |
| 2.799 NZ WHO haematolymphoid indolent non-hodgkin B cell lymphoma other histology |
| 2.800 NZ WHO haematolymphoid leukaemia histology |
| 2.801 NZ WHO haematolymphoid leukaemia histology (5th edition) |
| 2.802 NZ WHO haematolymphoid lymphoma excluding small lymphocytic disease histology |
| 2.803 NZ WHO haematolymphoid lymphoplasmacytic lymphoma histology |
| 2.804 NZ WHO haematolymphoid lymphoplasmacytic lymphoma histology (5th edition) |
| 2.805 NZ WHO haematolymphoid mantle cell lymphoma histology |
| 2.806 NZ WHO haematolymphoid mantle cell lymphoma histology (5th edition) |
| 2.807 NZ WHO haematolymphoid marginal zone lymphoma histology |
| 2.808 NZ WHO haematolymphoid mast cell sarcoma histology |
| 2.809 NZ WHO haematolymphoid mastocytosis other histology |
| 2.810 NZ WHO haematolymphoid mature T cell and natural killer cell leukeamia histology |
| 2.811 NZ WHO haematolymphoid mature T cell and natural killer cell leukeamia histology (5th edition) |
| 2.812 NZ WHO haematolymphoid mature T cell and natural killer cell neoplasm histology (5th edition) |
| 2.813 NZ WHO haematolymphoid mature T-cell and natural killer cell neoplasm other histology |
| 2.814 NZ WHO haematolymphoid monoclonal B cell lymphocytosis histology (5th edition) |
| 2.815 NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm histology |
| 2.816 NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm histology (5th edition) |
| 2.817 NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm other histology |
| 2.818 NZ WHO haematolymphoid myelodysplastic syndrome histology |
| 2.819 NZ WHO haematolymphoid myelodysplastic syndrome histology (5th edition) |
| 2.820 NZ WHO haematolymphoid myeloid proliferation or neoplasm other histology |
| 2.821 NZ WHO haematolymphoid myeloid/lymphoid neoplasm with eosinophilia and defining gene rearrangement histology (5th edition) |
| 2.822 NZ WHO haematolymphoid myeloma histology |
| 2.823 NZ WHO haematolymphoid myeloproliferative neoplasm other leukaemia histology |
| 2.824 NZ WHO haematolymphoid non Hodgkin lymphoma histology (5th edition) |
| 2.825 NZ WHO haematolymphoid peripheral T cell lymphoma histology (5th edition) |
| 2.826 NZ WHO haematolymphoid plasma cell neoplasm and other diseases with paraproteins other histology |
| 2.827 NZ WHO haematolymphoid plasma cell neoplasms and other diseases with paraproteins histology (5th edition) |
| 2.828 NZ WHO haematolymphoid plasmacytoid dendritic cell neoplasm histology |
| 2.829 NZ WHO haematolymphoid polycythaemia vera histology (5th edition) |
| 2.830 NZ WHO haematolymphoid primary CNS lymphoma histology |
| 2.831 NZ WHO haematolymphoid primary cutaneous T cell lymphoproliferative disorder histology |
| 2.832 NZ WHO haematolymphoid primary cutaneous T cell lymphoproliferative disorder histology (5th edition) |
| 2.833 NZ WHO haematolymphoid reactive B-cell rich lymphoid proliferations which mimic lymphoma histology (5th edition) |
| 2.834 NZ WHO haematolymphoid small lymphocytic lymphoma histology |
| 2.835 NZ WHO haematolymphoid systemic mastocytosis histology |
| 2.836 NZ WHO haematolymphoid T lymphoblastic leukemia histology |
| 2.837 NZ WHO haematolymphoid T-cell and natural killer cell neoplasm other histology |
| 2.838 NZ WHO haematolymphoid tumour histology (5th edition) |
| 2.839 NZ WHO heart primary histology |
| 2.840 NZ WHO hematolymphoid B cell lymphoid proliferation or lymphoma histology |
| 2.841 NZ WHO hematolymphoid histiocytic dendritic cell neoplasm histology |
| 2.842 NZ WHO hematolymphoid myeloid proliferation or neoplasm histology |
| 2.843 NZ WHO hematolymphoid stroma derived neoplasm of lymphoid tissue histology |
| 2.844 NZ WHO hematolymphoid T cell and NK cell lymphoid proliferation or lymphoma histology |
| 2.845 NZ WHO histology |
| 2.846 NZ WHO kidney primary histology |
| 2.847 NZ WHO lacrimal drainage system primary histology |
| 2.848 NZ WHO lacrimal gland primary histology |
| 2.849 NZ WHO lacrimal gland site histology |
| 2.850 NZ WHO liver site histology |
| 2.851 NZ WHO lower gastrointestinal primary histology |
| 2.852 NZ WHO lower gastrointestinal site histology |
| 2.853 NZ WHO male breast primary histology |
| 2.854 NZ WHO malignant differentiation excluding undifferentiated grade |
| 2.855 NZ WHO malignant differentiation grade |
| 2.856 NZ WHO malignant low high (differentiation) grade |
| 2.857 NZ WHO medical oncology histology |
| 2.858 NZ WHO meninges primary histology |
| 2.859 NZ WHO neuroendocrine neoplasm non neuroendocrine organ histology |
| 2.860 NZ WHO neuroendocrine pancreas histology |
| 2.861 NZ WHO neuroendocrine pancreas histology (5th edition) |
| 2.862 NZ WHO neuroendocrine pancreas primary histology |
| 2.863 NZ WHO neuroendocrine tumour gastroenteropancreatic (GEP-NET) primary histology |
| 2.864 NZ WHO neuroendocrine tumour grade |
| 2.865 NZ WHO neuroendocrine tumour non neuroendocrine organ primary histology |
| 2.866 NZ WHO neuroendocrine tumour non neuroendocrine organ primary histology (5th edition) |
| 2.867 NZ WHO neuroendocrine tumour pancreas primary histology (5th edition) |
| 2.868 NZ WHO oesophagus primary histology |
| 2.869 NZ WHO orbit histology |
| 2.870 NZ WHO orbit histology (5th edition) |
| 2.871 NZ WHO orbit primary histology |
| 2.872 NZ WHO ovary primary histology |
| 2.873 NZ WHO ovary site histology |
| 2.874 NZ WHO pancreas primary histology |
| 2.875 NZ WHO pancreas site histology |
| 2.876 NZ WHO penis primary histology |
| 2.877 NZ WHO penis site histology |
| 2.878 NZ WHO pericardium primary histology |
| 2.879 NZ WHO pericardium site histology |
| 2.880 NZ WHO peritoneum site histology |
| 2.881 NZ WHO pituitary neuroendocrine tumour primary histology |
| 2.882 NZ WHO pituitary neuroendocrine tumour primary histology (5th edition) |
| 2.883 NZ WHO pleural site histology |
| 2.884 NZ WHO prostate primary histology |
| 2.885 NZ WHO prostate site histology |
| 2.886 NZ WHO sclera primary histology |
| 2.887 NZ WHO small intestine primary histology |
| 2.888 NZ WHO small intestine site histology |
| 2.889 NZ WHO soft tissue and bone undifferentiated small round cell sarcoma histology |
| 2.890 NZ WHO soft tissue and bone undifferentiated small round cell sarcoma histology (5th edition) |
| 2.891 NZ WHO soft tissue histology |
| 2.892 NZ WHO soft tissue primary histology |
| 2.893 NZ WHO soft tissue site histology |
| 2.894 NZ WHO spinal cord site histology |
| 2.895 NZ WHO stomach primary histology |
| 2.896 NZ WHO testicular adnexa primary histology |
| 2.897 NZ WHO testicular adnexa site histology |
| 2.898 NZ WHO testis primary histology |
| 2.899 NZ WHO testis site histology |
| 2.900 NZ WHO thoracic benign histology |
| 2.901 NZ WHO thoracic benign histology (5th edition) |
| 2.902 NZ WHO thoracic ectopic tumour of thyroid and parathyroid origin histology |
| 2.903 NZ WHO thoracic ectopic tumour of thyroid and parathyroid origin histology (5th edition) |
| 2.904 NZ WHO thoracic haematolymphoid histology |
| 2.905 NZ WHO thoracic heart histology (5th edition) |
| 2.906 NZ WHO thoracic malignant histology |
| 2.907 NZ WHO thoracic mediastinum germ cell histology (5th edition) |
| 2.908 NZ WHO thoracic mediastinum haematolymphoid histology (5th edition) |
| 2.909 NZ WHO thoracic mesenchymal thorax histology |
| 2.910 NZ WHO thoracic neuroendocrine tumour grade |
| 2.911 NZ WHO thoracic non small cell lung histology |
| 2.912 NZ WHO thoracic non small cell lung histology (5th edition) |
| 2.913 NZ WHO thoracic pleura and pericardium histology |
| 2.914 NZ WHO thoracic pleura and pericardium histology (5th edition) |
| 2.915 NZ WHO thoracic precursor histology |
| 2.916 NZ WHO thoracic precursor histology (5th edition) |
| 2.917 NZ WHO thoracic primary histology |
| 2.918 NZ WHO thoracic small cell lung histology |
| 2.919 NZ WHO thoracic small cell lung histology (5th edition) |
| 2.920 NZ WHO upper gastrointestinal primary histology |
| 2.921 NZ WHO upper gastrointestinal site histology |
| 2.922 NZ WHO urethra primary histology |
| 2.923 NZ WHO urethra site histology |
| 2.924 NZ WHO urinary and male genital haematolymphoid histology (5th edition) |
| 2.925 NZ WHO urinary and male genital histology |
| 2.926 NZ WHO urinary and male genital histology (5th edition) |
| 2.927 NZ WHO urinary and male genital kidney germ cell histology |
| 2.928 NZ WHO urinary and male genital kidney histology |
| 2.929 NZ WHO urinary and male genital kidney histology (5th edition) |
| 2.930 NZ WHO urinary and male genital neuroendocrine histology |
| 2.931 NZ WHO urinary and male genital primary histology |
| 2.932 NZ WHO urinary and male genital prostate histology |
| 2.933 NZ WHO urinary and male genital prostate histology (5th edition) |
| 2.934 NZ WHO urinary and male genital testicular adnexa histology |
| 2.935 NZ WHO urinary and male genital testis germ cell histology |
| 2.936 NZ WHO urinary and male genital testis germ cell histology (5th edition) |
| 2.937 NZ WHO urinary and male genital testis histology |
| 2.938 NZ WHO urinary bladder primary histology |
| 2.939 NZ WHO urinary system site histology |
| 2.940 NZ WHO uterine corpus primary histology |
| 2.941 NZ WHO uterine corpus site histology |
| 2.942 NZ WHO uterine ligament site histology |
| 2.943 NZ WHO uterine primary histology |
| 2.944 NZ WHO uveal tract site histology |
| 2.945 NZ WHO vagina site histology |
| 2.946 NZ WHO vulva primary histology |
| 2.947 NZ WHO vulva site histology |
| 2.948 nz-datum-code |
| 2.949 nz-ethnic-group-code |
| 2.950 NZMT - CTPP |
| 2.951 NZMT - MP |
| 2.952 NZMT - MPUU |
| 2.953 NZMT - TPP |
| 2.954 nzmt-type-code |
| 2.955 NZPOCS |
| 2.956 oral-enrolment-termination-reason |
| 2.957 practitioner-additional-authorisation-code |
| 2.958 practitioner-scope-of-practice-code |
| 2.959 PractitionerRoleCode |
| 2.960 Pregnancies Summary - IPS |
| 2.961 Pregnancy Expected Delivery Date Method - IPS |
| 2.962 Pregnancy Status - IPS |
| 2.963 Problem Severity - IPS |
| 2.964 Problems (SNOMED CT) - IPS |
| 2.965 Results Coded Values Laboratory - IPS |
| 2.966 Results Coded Values Pathology - IPS |
| 2.967 Results Pathology Observation - IPS |
| 2.968 Results Presence/Absence - IPS |
| 2.969 Results Radiology Observation - IPS |
| 2.970 Results Specimen Collection Method - IPS |
| 2.971 Results Specimen Type - IPS |
| 2.972 Rheumatic fever care plan category |
| 2.973 Rheumatic fever care team participant role |
| 2.974 skin-to-skin-contact-end-reason-code |
| 2.975 Smoking status |
| 2.976 SNOMED CT Drug Therapy Status codes |
| 2.977 Standard classification of gender |
| 2.978 UCUM Codes |
| 2.979 UKPUL |
| 2.980 vaccine-code |
| 2.981 Vital Signs |
| 2.982 Additional Authorisation |
| 2.983 AdministrativeGender |
| 2.984 Admission source code |
| 2.985 Admission type code |
| 2.986 Agency type code |
| 2.987 AIR legacy codes |
| 2.988 AllergyIntoleranceCriticality |
| 2.989 AllergyIntoleranceSeverity |
| 2.990 Antiviral eligibility - criteria codes |
| 2.991 Antiviral eligibility - when symptoms started codes |
| 2.992 ATC classification system |
| 2.993 ATC classification system |
| 2.994 Australian and New Zealand Standard Industrial Classification |
| 2.995 Canshare testing non-snomed concepts |
| 2.996 canshare-test-nonsnomed |
| 2.997 Clinical code type code |
| 2.998 Clinical coding system code |
| 2.999 Concepts that are not yet formally published |
| 2.1000 Condition Clinical Status Codes |
| 2.1001 ContactPoint purpose |
| 2.1002 Country code 2 Alpha |
| 2.1003 country code 4 numeric |
| 2.1004 Coverage category |
| 2.1005 Coverage type |
| 2.1006 Datum codes |
| 2.1007 Domicile Code |
| 2.1008 DSM-IV |
| 2.1009 EDQM - Standard Terms |
| 2.1010 Funded Programme |
| 2.1011 Infant feeding method code |
| 2.1012 Information Source |
| 2.1013 ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code |
| 2.1014 ISO 639-2 Language Codes Alpha 3 |
| 2.1015 ISO 639-3 Language Codes Alpha 3 |
| 2.1016 Iwi and iwi-releated groups |
| 2.1017 Language classification code |
| 2.1018 Level 4 ethnicity codes |
| 2.1019 LOINC 2.76 |
| 2.1020 LOINC 2.77 |
| 2.1021 LOINC 2.78 |
| 2.1022 LOINC NZ local order code |
| 2.1023 LOINC_NZ_local_code |
| 2.1024 MedDRA LLT 26.0 CS |
| 2.1025 MedDRA LLT 27.0 CS |
| 2.1026 MedDRA LLT 27.1 CS |
| 2.1027 Medication status codes |
| 2.1028 MyDocumentMode |
| 2.1029 MyNewCS |
| 2.1030 Māori descent codes |
| 2.1031 New Zealand integrated care module |
| 2.1032 New Zealand integrated care module |
| 2.1033 New Zealand integrated care module |
| 2.1034 New Zealand integrated care module |
| 2.1035 Number of cord vessels code |
| 2.1036 Nutrition Care Process Terminology module |
| 2.1037 NZ cancer colorectal colonoscopy 6 week referral criteria |
| 2.1038 NZ cancer HL7 diagnostic report status |
| 2.1039 NZ cancer HL7 FHIR care plan status |
| 2.1040 NZ cancer HL7 FHIR condition verification status |
| 2.1041 NZ cancer HL7 FHIR request status |
| 2.1042 NZ cancer HL7 FHIR service request status |
| 2.1043 NZ cancer radiation oncology FSA prioritisation category |
| 2.1044 NZ cancer radiation oncology treatment prioritisation category |
| 2.1045 NZ Citizenship status |
| 2.1046 NZ ethnic group codes |
| 2.1047 NZ Purpose Of Use |
| 2.1048 NZ Residency status |
| 2.1049 NZVX immunisation codes |
| 2.1050 Omaha System CodeSystem |
| 2.1051 Oral health enrolment termination reason code |
| 2.1052 PHO |
| 2.1053 PractitionerRole status reason |
| 2.1054 Registration Status of Practitioners |
| 2.1055 Rheumatic fever diagnostic certainty |
| 2.1056 Scope of practice |
| 2.1057 Skin to skin end reason |
| 2.1058 SNOMED CT core |
| 2.1059 SNOMED CT core |
| 2.1060 SNOMED CT core |
| 2.1061 SNOMED CT core |
| 2.1062 SNOMED CT core |
| 2.1063 Temporary rheumatic fever codes |
| 2.1064 Type of Alias |
| 2.1065 Unified Code for Units of Measure (UCUM) |
| 2.1066 Uterotonic drugs administered status code |
| 2.1067 v3 Code System ActReason |
| 2.1068 Vaccine Administered Code Set (CVX) |
| 2.1069 absent-or-unknown-devices-uv-ips |
| 2.1070 absent-or-unknown-problems-uv-ips |
| 2.1071 allergy-intolerance-uv-ips |
| 2.1072 diagnostic-report-status |
| 2.1073 medication-snomed-absent-unknown-uv-ips |
| 2.1074 nhi-use-code |
| 2.1075 NZ-residency-source-code |
| 2.1076 observation-codes |
| 2.1077 problems-snomed-absent-unknown-uv-ips |
| 2.1078 procedures-snomed-absent-unknown-uv-ips |
| 2.1079 request-status |
| 2.1080 results-radiology-numobs-snomed-dicom-uv-ips |
| 2.1081 results-radiology-txtobs-snomed-dicom-loinc-uv-ips |
| 2.1082 service-type |
 2.1083 vaccines-uv-ips |
